XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net product revenues $ 80,732 $ 45,609 $ 214,227 $ 103,454
Cost of product sold 14,604 7,890 37,701 17,820
Gross profit 66,128 37,719 176,526 85,634
Operating expenses:        
Research and development 11,739 4,230 22,916 11,829
Sales and marketing 16,480 12,601 49,009 38,297
General and administrative 16,856 10,508 45,704 26,280
Total operating expenses 45,075 27,339 117,629 76,406
Operating income 21,053 10,380 58,897 9,228
Loss on debt extinguishment (26,146)   (26,146) (22,639)
Other income (expense), net   (1,525) (15) (3,071)
Interest expense, net (5,429) (6,946) (19,783) (20,254)
(Loss) income before income taxes (10,522) 1,909 12,953 (36,736)
Income tax benefit (expense) 902   (1,070)  
Net (loss) income and comprehensive (loss) income (9,620) 1,909 11,883 (36,736)
Accumulation of dividends on preferred stock   (6,013)   (26,904)
Net (loss) income available to common stockholders $ (9,620) $ (4,104) $ 11,883 $ (63,640)
(LOSS) EARNINGS PER SHARE:        
Basic $ (0.17) $ (0.14) $ 0.21 $ (4.15)
Diluted $ (0.17) $ (0.14) $ 0.20 $ (4.15)
Weighted average number of shares of common stock - basic 57,722,163 30,212,959 57,188,101 15,324,362
Weighted average number of shares of common stock - diluted 57,722,163 30,212,959 58,776,158 15,324,362